SEC Form 4 · accession 0001179110-18-008404
SELECT MEDICAL HOLDINGS CORP · SEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert A Ortenzio
Officer — Exec. Chairman and Co-Founder · Director
Period of report
Jun 8, 2018
Accepted (ET)
Jun 12, 2018 · 5:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001320414
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2018 | S | 152 | $18.50 | D | 6,986,249 | D | |
| Common StockF2 | Jun 11, 2018 | S | 119,253 | $18.63 | D | 6,866,996 | D | |
| Common StockF3 | Jun 12, 2018 | S | 73,448 | $18.66 | D | 6,793,548 | D | |
| Common StockF4 | holding | — | — | — | 800,000 | I | By the Robert A. Ortenzio July 2017 GRAT | |
| Common StockF4 | holding | — | — | — | 31,886 | I | By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio | |
| Common StockF4 | holding | — | — | — | 31,886 | I | By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio | |
| Common StockF4 | holding | — | — | — | 31,885 | I | By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio | |
| Common StockF4 | holding | — | — | — | 2,750,000 | I | By the Rocco A. Ortenzio Descendants Trust | |
| Common StockF4 | holding | — | — | — | 1,300,000 | I | By the Robert A. Ortenzio Descendants Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017.
- F2The price reported in this column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.70, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F3The price reported in this column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.95, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F4The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership to the reported securities except to the extent of his pecuniary interest therein.